Topic

Senior Vice President, Customer Success, FourKites

Articles

Increase in new treatments also brings increase in logistical challenges for pharma.

Shedding Light on Global Pharmaceutical Supply Chains

Julian Upton is a contributing editor for 

As borders shut down during the pandemic, pharma learned some lessons about sourcing.

Supply Chain Procurement

The 2013 Drug Supply Chain Security Act (DSCSA) established a framework for exchanging data when products are transacted throughout the US pharma supply chain. Its goal, by November 2023, is to enable unit-level traceability in a secure, interoperable manner. HDA’s Chip Davis talks about how pharma manufacturers must prepare for this implementation deadline.

The Drug Supply Chain Security Act Deadline is Sooner Than You Think

Rafael Teixeira on building an end-to-end cold chain strategy to support global storage and distribution efforts.

Cold Chain: Delivering Innovative Specialty Pharmaceutical Products

Additional assistance necessary for patients prescribed specialty therapies.

Lessons Learned Working with Millions of Patients on Specialty Medications 

Jill Wechsler is Pharm Exec's Washington Corespondent

The Biden administration has rolled out a broad initiative to promote domestic production of critical materials, including medicines and their ingredients.

White House Promotes US Drug Manufacturing to Secure Access to Vital Medicines

) and and Lavan Thasarathakumar, Thasa Consulting.

Hannah Schofield and Lavan Thasarathakumar discuss what blockchain is, how it could help improve pharmaceutical supply chains, and the COVID-19 vaccine supply chain in particular, and touches on where we are already seeing blockchain technology being used in this area.

Blockchain, COVID-19 and the Pharmaceutical Supply Chain

To effectively combat the looming threat of antimicrobial resistance, we must prioritize working together to strengthen and more responsibly manage global supply chains.


Better Supply Chains Can Better Tackle Threats to Public Health

Gina Parry, National Account Manager, VAI

If telehealth is here to stay, how is the industry adjusting?

Keeping Up with Telehealth: Pharma’s Evolution 

Mitigating the risks of development, authorization, and marketing for new therapies following "new normal" created by COVID-related violations. 